inTEST Thermal Solutions and Stellar Scientific Partner to Provide North Sciences Ultra-Low Temperature Biomedical Storage Solutions to U.S. Government Agencies
The North Sciences Ultra-Low Temperature (ULT) biomedical freezers are designed for -86°C cold storage of biomedical samples, vaccines, and research materials. For life sciences applications, maintaining critical temperatures is paramount for the integrity of the samples and the research that depends on them. Compromised samples can lead to incalculable losses both in terms of dollars and research hours. North Sciences provides highly reliable solutions that include redundant controls in order to avoid these issues.
Stellar Scientific and inTEST Thermal Solutions are both leaders in the industry, with a reputation for providing high-quality products and exceptional customer service. The partnership will allow the companies to leverage their respective strengths to better serve their customers and expand their reach into a broad spectrum of the government market.
About Stellar Scientific
Stellar Scientific is a leading supplier of high-quality laboratory equipment, supplies, and services. Stellar supports scientific research globally, partnering with biotechnology firms, pharmaceutical companies, government agencies, the military, academic institutions, food and petroleum product companies, high schools and more. Based in
About inTEST Corporation
inTEST Corporation is a global supplier of innovative test and process solutions for use in manufacturing and testing in key target markets which include automotive, defense/aerospace, industrial, life sciences, and security, as well as both the front-end and back-end of the semiconductor manufacturing industry. Backed by decades of engineering expertise and a culture of operational excellence, inTEST solves difficult thermal, mechanical, and electronic challenges for customers worldwide while generating strong cash flow and profits. inTEST’s strategy leverages these strengths to grow organically and with acquisitions through the addition of innovative technologies, deeper and broader geographic reach, and market expansion. For more information, visit www.intest.com.
About inTEST Thermal Solutions
inTEST Thermal Solutions (iTS) specializes in the design and manufacture of thermal test, process cooling, and biomedical cold storage systems. Our breadth of products and in-house engineering capabilities allow us to be a single-partner-solution for critical temperature control applications. We are recognized globally for our expertise in precise control of extreme thermal environments, from -185 to +500°C, with rapid transitions or long dwell times. The iTS family includes four product brands:
Forward-Looking Statements
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements do not convey historical information but relate to predicted or potential future events and financial results, such as statements of the Company’s plans, strategies and intentions, or our future performance or goals, that are based upon management's current expectations. These forward-looking statements can often be identified by the use of forward-looking terminology such as “believes,” “expects,” “intends,” “may,” “will,” “should,” “plans,” “projects,” “forecasts,” “outlook,” “anticipates,” “targets,” “estimates,” or similar terminology. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.
Such risks and uncertainties include, but are not limited to, any mentioned in this press release as well as the Company’s ability to execute on its 5-Point Strategy, realize the potential benefits of acquisitions and successfully integrate any acquired operations, grow the Company’s presence in its key target and international markets, manage supply chain challenges, convert backlog to sales and to ship product in a timely manner; the success of the Company’s strategy to diversify its markets; the impact of inflation on the Company’s business and financial condition; the impact of the COVID-19 pandemic on the Company’s business, liquidity, financial condition and results of operations; indications of a change in the market cycles in the semi market or other markets served; changes in business conditions and general economic conditions both domestically and globally including rising interest rates and fluctuation in foreign currency exchange rates; changes in the demand for semiconductors; access to capital and the ability to borrow funds or raise capital to finance potential acquisitions or for working capital; changes in the rates and timing of capital expenditures by the Company’s customers; and other risk factors set forth from time to time in the Company’s
View source version on businesswire.com: https://www.businesswire.com/news/home/20230418005265/en/
inTEST Corporation
Chief Financial Officer and Treasurer
Tel: (856) 505-8999
Investors:
dpawlowski@keiadvisors.com
lkiernan@keiadvisors.com
Tel: (716) 843-3908, (914) 598-7733
Source: inTEST Corporation